MMP-1 Polymorphic Expression in Aortic Endothelial Cells: Possible Role in Lesion Development in Smokers and Nonsmokers

Cardiovascular Toxicology

Volumn 4, Issue 1, 2004, Pages 75-83

  Nordskog, Brian K ^a   Blixt, Allison D ^b   Zieske, Arthur W ^c   Hellmann, Gary M ^a,b,d  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b R J REYNOLDS TOBACCO COMPANY   (United States)

^c LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Genotyping; Interstitial collagenase; MMP 1; PDAY; SNP

Indexed keywords

CIGARETTE SMOKE CONDENSATE; INTERSTITIAL COLLAGENASE; MESSENGER RNA;

ADULT; AORTA; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CAUCASIAN; CELL CULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME MECHANISM; GENE EXPRESSION; GENOTYPE; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; VASCULAR ENDOTHELIUM;

ARTERIES; ARTERIOSCLEROSIS; CELLS, CULTURED; CHOLESTEROL; ELECTROPHORESIS, AGAR GEL; ENDOTHELIAL CELLS; GENE EXPRESSION; GENOTYPE; HUMANS; LIPOPROTEINS; MATRIX METALLOPROTEINASE 1; MYOCARDIUM; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMORPHISM, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SMOKING;

NICOTIANA TABACUM;

EID: 1942453906     PISSN: 15307905     EISSN: None     Source Type: Journal    
DOI: 10.1385/CT:4:1:75     Document Type: Article

References (40)

1. Cawston, T., Carrere, S., Catterall, J., Duggleby, R., Elliott, S., Shingleton, B., et al. (2001). Matrix metalloproteinases and TIMPs: properties and implications for the treatment of chronic obstructive pulmonary disease. Novartis Found. Symp. 234:205-218.
2. Huang, Y., Mironova, M., and Lopes-Virella, M.F. (1999). Oxidized LDL stimulates matrix metalloproteinase-1 expression in human vascular endothelial cells. Arterioscler. Thromb. Vasc. Biol. 19:2640-2647.
3. Galis, Z.S., Sukhova, G.K., Lark, M.W., and Libby, P. (1994). Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J. Clin. Invest. 94:2493-2503.
4. MacDougall, J.R. and Matrisian, L.M. (1995). Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis. Cancer Metastasis Rev. 14:351-362.
5. Murray, G.I., Duncan, M.E., O'Neil, P., McKay, J.A., Melvin, W.T., and Fothergill, J.E. (1998). Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer. J. Pathol. 185:256-261.
6. Yoshihara, Y., Nakamura, H., Obata, K., Yamada, H., Hayakawa, T., Fujikawa, K., et al. (2000). Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis. Ann. Rheum. Dis. 59:455-461.
7. Sternlicht, M.D. and Werb, Z. (2001). How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell Dev. Biol. 17:463-516.
8. Buttice, G., Duterque-Coquillaud, M., Basuyaux, J.P., Carrere, S., Kurkinen, M., and Stehelin, D. (1996). Erg, an Ets-family member, differentially regulates human collagenasel (MMP1) and stromelysin1 (MMP3) gene expression by physically interacting with the Fos/Jun complex. Oncogene 13:2297-2306.
9. Rutter, J.L., Mitchell, T.I., Buttice, G., Meyers, J., Gusella, J.F., Ozelius, L.J., et al. (1998). A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res. 58:5321-5325.
10. Benbow, U. and Brinckerhoff, C.E. (1997). The AP-1 site and MMP gene regulation: what is all the fuss about? Matrix Biol. 15:519-526.
11. Liu, Y.Z., Dawson, S.J., Gerster, T., Friedl, E., Pengue, G., Matthias, P., et al. (1996). The ability of the inhibitory domain of the POU family transcription factor Oct-2 to interfere with promoter activation by different classes of activation domains is dependent upon the nature of the basal promoter elements. J. Biol. Chem. 271:20853-20860.
12. Boyle, D.L., Sajjadi, F.G., and Firestein, G.S. (1996). Inhibition of synoviocyte collagenase gene expression by adenosine receptor stimulation. Arthritis Rheum. 39:923-930.
13. Sharrocks, A.D. (2001). The ETS-domain transcription factor family. Nat. Rev. Mol. Cell Biol. 2:827-837.
14. Bassuk, A.G. and Leiden, J.M. (1995). A direct physical association between ETS and AP-1 transcription factors in normal human T cells. Immunity 3:223-237.
15. Basuyaux, J.P., Ferreira, E., Stehelin, D., and Buttice, G. (1997). The Ets transcription factors interact with each other and with the c-Fos/c-Jun complex via distinct protein domains in a DNA-dependent and -independent manner. J. Biol. Chem. 272:26188-26195.
16. Ye, S., Dhillon, S., Turner, S.J., Bateman, A.C., Theaker, J.M., Pickering, R.M., et al. (2001). Invasiveness of cutaneous malignant melanoma is influenced by matrix metalloproteinase 1 gene polymorphism. Cancer Res. 61:1296-1298.
17. Ghilardi, G., Biondi, M.L., Mangoni, J., Leviti, S., DeMonti, M., Guagnellini, E., et al. (2001). Matrix metalloproteinase-1 promoter polymorphism 1G/2G is correlated with colorectal cancer invasiveness. Clin. Cancer Res. 7:2344-2346.
18. Constantin, A., Lauwers-Cances, V., Navaux, F., Abbal, M., van Meerwijk, J., Mazieres, B., et al. (2002). Collagenase-1 (MMP-1) and HLA-DRB1 gene polymorphisms in rheumatoid arthritis: a prospective longitudinal study. J. Rheumatol. 29:15-20.
19. Katsuda, S., Okada, Y., Minamoto, T., Oda, Y., Matsui, Y., and Nakanishi, I. (1992). Collagens in human atherosclerosis. Immunohistochemical analysis using collagen type-specific antibodies. Arterioscler. Thromb. 12:494-502.
20. Davies, M.J. and Thomas, A.C. (1985). Plaque fissuring-the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br. Heart J. 53:363-373.
21. Falk, E. (1985). Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion. Circulation 71:699-708.
22. van der Wal, A.C., Becker, A.E., van der Loos, C.M., and Das, P.K. (1994). Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 89:36-44.
23. Henney, A.M., Wakeley, P.R., Davies, M.J., Foster, K., Hembry, R., Murphy, G., et al. (1991). Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Proc. Natl. Acad. Sci. USA 88:8154-8158.
24. Lee, E., Grodzinsky, A.J., Libby, P., Clinton, S.K., Lark, M.W., and Lee, R.T. (1995). Human vascular smooth muscle cell-monocyte interactions and metalloproteinase secretion in culture. Arterioscler. Thromb. Vasc. Biol. 15:2284-2289.
25. Nordskog, B.K., Blixt, A.D., Morgan, W.T., Fields, W.R., and Hellmann, G.M. (2003). Matrix-degrading and proinflammatory changes in human vascular endothelial cells exposed to cigarette smoke condensate. Cardiovasc. Toxicol. 3:101-118.
26. Hojo, Y., Ikeda, U., Takahashi, M., Sakata, Y., Takizawa, T., Okada, K., et al. (2000). Matrix metalloproteinase-1 expression by interaction between monocytes and vascular endothelial cells. J. Mol. Cell Cardiol. 32:1459-1468.
27. Zhu, Y., Hojo, Y., Ikeda, U., Takahashi, M., and Shimada, K. (2000). Interaction between monocytes and vascular smooth muscle cells enhances matrix metalloproteinase-1 production. J. Cardiovasc. Pharmacol. 36:152-161.
28. Kannel, W.B., McGee, D.L., and Castelli, W.P. (1984). Latest perspectives on cigarette smoking and cardiovascular disease: the Framingham study. J. Cardiac Rehabil. 4:267-277.
29. US Department of Health and Human Services, Public Health Service, and Office on Smoking and Health. (1993). The health consequences of smoking: cardiovascular disease. A report of the Surgeon General. DHHS Publication (PHS) 84-50204.
30. Ottesen, M.M., Jorgensen, S., Kjoller, E., Videbaek, J., Kober, L., and Torp-Pedersen, C. (1999). Age-distribution, risk factors and mortality in smokers and non-smokers with acute myocardial infarction: a review. TRACE study group. Danish Trandolapril Cardiac Evaluation. J. Cardiovasc. Risk 6:307-309.
31. McGill, H.C. Jr., McMahan, C.A., Zieske, A.W., Malcom, G.T., Tracy, R.E., and Strong, J.P. (2001). Effects of non-lipid risk factors on atherosclerosis in youth with a favorable lipoprotein profile. Circulation 103:1546-1550.
32. Diana, J.N. and Vaught, A. (1990). Research cigarettes. Lexington, KY: The University of Kentucky Printing Services.
33. Bombick, B.R., Murli, H., Avalos, J.T., Bombick, D.W., Morgan, W.T., Putnam, K.P. et al. (1998). Chemical and biological studies of a new cigarette that primarily heats tobacco. Part 2. In vitro toxicology of mainstream smoke condensate. Food Chem. Toxicol. 36:183-190.
34. Hellmann, G.M., Fields, W.R., and Doolittle, D.J. (2001). Gene expression profiling of cultured human bronchial epithelial and lung carcinoma cells. Toxicol. Sci. 61:154-163.
35. Hixson, J.E. (1991). Apolipoprotein E polymorphisms affect atherosclerosis in young males. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) research group. Arterioscler. Thromb. 11:1237-1244.
36. Zhu, Y., Spitz, M.R., Lei, L., Mills, G.B., and Wu, X. (2001). A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility. Cancer Res. 61:7825-7829.
37. Rainwater, D.L., McMahan, C.A., Malcom, G.T., Scheer, W.D., Roheim, P.S., McGill, H.C. Jr., et al. (1999). Lipid and apolipoprotein predictors of atherosclerosis in youth: apolipoprotein concentrations do not materially improve prediction of arterial lesions in PDAY subjects. The PDAY Research Group. Arterioscler. Thromb. Vasc. Biol. 19:753-761.
38. Wyatt, C.A., Coon, C.I., Gibson, J.J., and Brinckerhoff, C.E. (2002). Potential for the 2G single nucleotide polymorphism in the promoter of matrix metalloproteinase to enhance gene expression in normal stromal cells. Cancer Res. 62:7200-7202.
39. Ikeda, U., Shimpo, M., Ohki, R., Inaba, H., Takahashi, M., Yamamoto, K., et al. (2000). Fluvastatin inhibits matrix metalloproteinase-1 expression in human vascular endothelial cells. Hypertension 36:325-329.
40. Aikawa, M., Rabkin, E., Okada, Y., Voglic, S.J., Clinton, S.K., Brinckerhoff, C.E., et al. (1998). Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: a potential mechanism of lesion stabilization. Circulation 97:2433-2444.